Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Similar documents
Ischemic Heart Disease

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

12 Lead EKG Chapter 4 Worksheet

Results of Ischemic Heart Disease

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

Laboratory diagnosis of heart diseases: Cardiometabolic risk AMI Heart failure

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Chest pain affects 20% to 40% of the general population during their lifetime.

Acute Myocardial Infarction

Diagnosis and Management of Acute Myocardial Infarction

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Myocardial Infarction

1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).

Ischemic heart disease

Cardiac Pathology & Rehabilitation

BIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS. As. MARUSHCHAK M.I.

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Objectives. Acute Coronary Syndromes; The Nuts and Bolts. Overview. Quick quiz.. How dose the plaque start?

Biomarkers of myocardial infarction. Dr. Mamoun Ahram Cardiovascular system, 2013

Ischaemic Heart Disease

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Acute coronary syndromes

Arteriosclerosis & Atherosclerosis

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011

In the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

Classification of lab tests useful in cardiac disease Biochemical markers in Acute Coronary Syndromes (ACS) Redefinition of Myocardial Infarction (MI)

To estimate the serum level of N-terminal pro-brain natriuretic peptide levels in acute coronary syndrome

FastTest. You ve read the book now test yourself

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Biomarkers of Cardiovascular diseases. By Dr. Gouse Mohiddin Shaik

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Cardiac Pathology 2: Heart Failure, Ischemic Heart Disease and other assorted stuff. Kris=ne Kra>s, M.D.

Heart Disorders. Cardiovascular Disorders (Part B-1) Module 5 -Chapter 8. Overview Heart Disorders Vascular Disorders

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

Health and Disease of the Cardiovascular system

MYOCARDIALINFARCTION. By: Kendra Fischer

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Chest Pain. Dr Robert Huggett Consultant Cardiologist

CHAPTER-I MYOCARDIAL INFARCTION

Acute Coronary Syndrome. Emergency Department Updated Jan. 2017

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM


Heart failure congestive heart failure, or CHF

Cardiac Pathophysiology

LAB 4: THE MUSCLE AND CARDIOVASCULAR SYSTEM THE MUSCLE AND CARDIOVASCULAR SYSTEM

Hypertension Coronary artery disease

Ischemic Heart Diseases. Dr. Nabila Hamdi MD, PhD

INFLAMM-O-WARS ACTIVITY 4B. Clumps and Bumps: A Look at Atherosclerosis. Student Activity Page 4B. Introduction. Background A LOOK AT ATHEROSCLEROSIS

BIOCHEMICAL EXAMINATION OF ACUTE MYOCARDIAL INFARCTION. Written by Lenka Fialová, translated by Jan Pláteník

Cho et al., 2009 Journal of Cardiology (2009), 54:

PATIENTS AND METHODS:

Cardiovascular Diseases and Diabetes

The focus of this week s lab will be pathology of the cardiovascular system.

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories

EDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE

Supplementary Table 1. Details of the components of the primary composite endpoint

MWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)

Ischemic heart disease (IHD) Dr: Salah Ahmed

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber

BLOOD PRESSURE. Unit 3: Transportation and Respiration

Observe the effects of atherosclerosis on the coronary artery lumen

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

ATHEROSCLEROSIS. Secondary changes are found in other coats of the vessel wall.

Unit 1: Human Systems. The Circulatory System

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute

Electrocardiography. Hilal Al Saffar College of Medicine,Baghdad University

AIMS: CHEST PAIN. Causes of chest pain. Causes of chest pain: Cardiac causes: Acute coronary syndromes pericarditis thoracic aortic dissection

Prehospital and Hospital Care of Acute Coronary Syndrome

Heart Disease. Signs and Symptoms

Lnformation Coverage Guidance

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?

The Universal Definition of Myocardial Infarction 3 rd revision, 2012

YOUR INFORMATION. Ischemic Heart Disease

Acute Coronary Syndrome

Practitioner Education Course

Chapter 18. Diet and Health

Cardiovascular Concerns in Intermediate Care

Chest Pain Accreditation ACS Education

CLINICAL OUTCOME Vs SURROGATE MARKER

Pyruvate + NADH + H + ==== Lactate + NAD +

Clinical Policy: Cardiac Biomarker Testing for Acute Myocardial Infarction Reference Number: CP.MP.156

Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Continuing Medical Education Post-Test

Normal blood vessels A= artery V= vein

ΒΙΟΔΕΙΚΤΕΣ ΣΤΗΝ ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ. ΔΗΜΗΤΡΙΟΣ ΤΟΥΣΟΥΛΗΣ Καθηγητής Καρδιολογίας

Circulation and Cardiac Emergencies. Emergency Medical Response

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Structure and organization of blood vessels

Myocardial infarction

Transcription:

Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014

Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain, and takes place when there is interrupted blood supply to myocytes and necrosis follows

Coronary artery disease Clinical presentation: Angina pectoris: Chest pain: dull or stabbing pain, radiating to the arm or jaw Associated with shortness of breath, diaphoresis, nausea and vomiting Clinical classification of angina: Stable angina: pain occurs only with exertion Unstable angina: pain occurs at rest Myocardial infarction: pain persists without interruption and irreversible myocyte damage has occurred

Causes of coronary artery disease Type Atherosclerosis or ischemic heart disease (IHD) Spasm Emboli Congenital Comments Most common. Risk factors: HT, Chol, DM, smoking and family history Most prevalent in Japanese. Mediated by histamine, serotonin, catecholamine and endotheliumderived factors Rare, may occur from vegetations in patients with endocarditis 1-2% of population, mostly asymptomatic

Atherosclerosis Affects medium and large vessels Inflammatory process that begins early in life and results in the deposition of lipid, fibrin and calcium in the intimal layers of the arteries; which harden, narrow and eventually occlude the vessel Exact mechanism is unclear

Response to injury theory Endothelium is damagedby oxidized lipoprotein, infectious agents, glucose, homocysteine, smoking or HT?? LDL migrates into intima LDL oxidizes produces VCAM-1 and MCP-1 Attracts monocytes into intima Macrophages Macrophages take up oxidezed LDL Foam cells Growth factors and cytokines produced proliferation of smooth muscle cells and secrete collagen cap formation covering lipids This plaques grows and eventually blocks the lumen blood flow leads to ischemia

Risk factors for IHD Primary Genetic predisposition HT Smoking Hyperlipidaemia Life style factors Nutrition Fat Antioxidants Salt intake Environmental influence in early life Secondary Age Male sex Lack of exercise Obesity DM Stress Alcohol Ethnicity Socioeconomic factors Homocysteine CRP (C-reactive protein)

Acute coronary syndrome Definition:ACS is used when symptoms and signs are indicative of myocardial ischemia Classification: MI with typical ST segment elevation (STEMI) MI without ST segment elevation (NSTEMI) Unstable angina It is vital to be able to diagnose MI early to start thrombolytic treatment and improve patient survival

WHO criteria for MI diagnosis Include two of the three criteria: History of chest pain ECG changes Elevated troponin or CK-MB

Biochemical diagnosis of acute MI Injured myocardial cells leak enzymes and proteins and these enzymes and proteins (or cardiac biomarkers) are measured to determine if a MI is present

Characteristics of cardiac markers Cardiac marker Rise (hour) Peak (hour) Time to return to normal (day) CK 3-8 10-24 3-4 CK-MB 3-8 10-24 2-3 LD1 8-12 72-144 8-14 Myoglobin 1-3 6-9 1 Troponin I 3-8 24-48 4-10 Troponin T 3-8 24-48 4-10

Time course of cardiac enzymes after acute MI

CK-MB Cardiac marker Rise (hour) Peak (hour) Time to return to normal (day) CK 3-8 10-24 3-4 CK-MB 3-8 10-24 2-3 The pattern of CK-MB release may be influenced by: The size of the infarct Concomitant skeletal muscle injury Composition of myocardium Reperfusion (after thrombolytic therapy or spontaneous)

Injury to skeletal muscle may the absolute amount of CKMB but the relative concentration is usually <5 % Measurement of CK-MB mass is more specific for MI than CK-MB activity measurement. Sensitivity of CK-MB: On admission: 17-62 % 3 hrs: 92-100 % The sensitivity of CK-MB improves with serial measurements at 0, 3, 6, and 9 hours after presentation

Troponins Troponin consists of three proteins T, C and I where it is a regulator complex of muscle Troponin T and I are very cardiac specific

Sensitivity of troponin I and T for MI diagnosis 100% by 12 hours after onset of pain Disadvantages of Troponins Troponin T is cleared by the kidneys, thus may be in renal failure Not good at detection of MI in early hours But more sensitive troponin assays are developed which could diagnose MI within 3 hours after chest pain onset.

Cardiac marker Rise (hour) Peak (hour) Time to return to normal (day) Troponin I 3-8 24-48 4-10 TroponinT 3-8 24-48 4-10 Elevated troponin are seen in other conditions indicative of myocardial damage, where it is a poor prognostic sign Sepsis Pulmonary Embolism Hypothyroidism Cardiac failure Pericarditis Myocarditis

Increase in troponin after A: Acute Myocardial infarction B: Minor Myocardial infarction C: Myocarditis www.circ.ahajournal.org

Myoglobin Cardiac marker Rise (hour) Peak (hour) Time to return to normal (day) Myoglobin 1-3 6-9 1 Myoglobin is an oxygen-carrying haem protein present in skeletal and cardiac muscle Due to is small size it is released earlier than other proteins from damaged cells Useful biomarker to diagnose early MI A negative result will exclude MI, but a positive result needs to be confirmed

Important clinical facts CK-MB and troponins do not start to rise until 3-8 hours after infarction, thus not useful to diagnose early MI A negative myoglobin test in the early hours will exclude MI By 12 hours, troponins are 100 % sensitive thus important in late diagnosis of MI

Acute IM presenting within 12 hours are treated with thrombolytic treatment To assess if thrombolytic treatment has been successful we need to look at the increased release of cardiac markers, wash out phenomenon. Myoglobin is the best reperfusion marker Diagnosing myocardial ischemia after cardiac and non-cardiac surgery can be done with troponins as CK and CK-MB are released by injured skeletal tissue A high troponin in patients with unstable angina predicts higher mortality

Investigation of patients suspected of heart failure CXR ECG Laboratory: FBC: exclude anaemia UCE: / Potassium, Sodium, renal function Mg: Mg due to long term diuretic use LFT and thyroid function test BNP or NT-pro BNP

BNP (Brain naturetic peptide)is released in heart failure due to left ventricular function which leads to cardiac output Both BNP and NT-proBNP (fragment of probnp) are elevated in heart failure. Many laboratories measure NT-proBNP because is more stable in vitro (tube) Thus if BNP or NT-proBNP is negative heart failure can be excluded BNP and NT-proBNP is a prognostic marker in heart failure as well

References 1. Swaminathan R (ed). Handbook of Clinical Biochemistry, 2 th Ed 2011. World Scientific New Jersey: p 299-354. 2. Marshall WJ, Bangert SK (eds). Clinical Chemistry, 6 th Ed 2008. Mosby Edinburgh: p 271-293. 3. McPhee SJ, Hammer GD (eds). Pathophysiology of Disease: An Introduction to Clinical Medicine, 6 th Ed 2010. McGraw Hill Medical New York: p 275-278. 4. www.circ.ahajournal.org